Clinical validation of the tempus xT next-generation targeted oncology sequencing assay

We developed and clinically validated a hybrid capture next generation sequencing assay to detect somatic alterations and microsatellite instability in solid tumors and hematologic malignancies. This targeted oncology assay utilizes tumor-normal matched samples for highly accurate somatic alteration...

Descripción completa

Detalles Bibliográficos
Autores principales: Beaubier, Nike, Tell, Robert, Lau, Denise, Parsons, Jerod R., Bush, Stephen, Perera, Jason, Sorrells, Shelly, Baker, Timothy, Chang, Alan, Michuda, Jackson, Iguartua, Catherine, MacNeil, Shelley, Shah, Kaanan, Ellis, Philip, Yeatts, Kimberly, Mahon, Brett, Taxter, Timothy, Bontrager, Martin, Khan, Aly, Huether, Robert, Lefkofsky, Eric, White, Kevin P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481324/
https://www.ncbi.nlm.nih.gov/pubmed/31040929
http://dx.doi.org/10.18632/oncotarget.26797

Ejemplares similares

Ejemplares similares